Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch^® 3-dimensional genomic regulatory immuno-genetic profiling.

IF 7.5 2区医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL

Journal of Translational Medicine Pub Date : 2025-10-08 DOI:10.1186/s12967-025-07203-w

Ewan Hunter, Heba Alshaker, Oliver Bundock, Cicely Weston, Shekinah Bautista, Abel Gebregzabhar, Anya Virdi, Joseph Croxford, Ann Dring, Ryan Powell, Dominik Vugrinec, Caroline Kingdon, Carol Wilson, Sarah Dowrick, Jayne Green, Alexandre Akoulitchev, Dmitri Pchejetski

引用次数: 0

查看原文本刊更多论文

使用EpiSwitch®三维基因组调控免疫基因图谱开发和验证肌痛性脑脊髓炎/慢性疲劳综合征（ME/CFS）的血液诊断生物标志物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Translational Medicine 医学-医学：研究与实验

CiteScore

10.00

自引率

1.40%

发文量

537

审稿时长

1 months

期刊介绍： The Journal of Translational Medicine is an open-access journal that publishes articles focusing on information derived from human experimentation to enhance communication between basic and clinical science. It covers all areas of translational medicine.

Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch® 3-dimensional genomic regulatory immuno-genetic profiling.

Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch^® 3-dimensional genomic regulatory immuno-genetic profiling.